Come up with a name for your new list and we'll add to it:
ProteoTech raised a round of funding on February 21, 2002. Investors include
National Institutes of Health.
ProteoTech is a private drug development company focused on targeting amyloid diseases. ProteoTech is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of…